Nida Ashraf

Nida Ashraf serves as Assistant Professor of Medicine at the University of Maryland School of Medicine, holding a primary appointment in the Department of Medicine and an additional role in the Division of Clinical Care and Research at the Institute of Human Virology. Her clinical expertise focuses on infectious diseases within immunocompromised populations, including transplant recipients and patients with hematological malignancies.

Her educational background includes:

• MBBS from Sindh Medical College, Dow University of Health Sciences (2006-2011)
• Internal Medicine Residency at Griffin Hospital (Yale-affiliated) (2015-2018)
• Infectious Diseases Fellowship at University of Kansas School of Medicine (2018-2020)
• Advanced Fellowship in Immunocompromised Host ID at UNC Chapel Hill (2023-2024)

Dr. Ashraf's research centers on infection prevention and management in immunocompromised hosts, with specific emphasis on:

• Immunocompromised Host Infections
• Mycobacterial and Endemic Mycoses
• LVAD-related infections
• Antimicrobial Stewardship protocols

Her publication record (2015-2022) demonstrates evolving expertise from epidemiological studies in Pakistan to specialized clinical research on fungal infections, transplant complications, and device-associated infections. Key trends include geographic mapping of endemic mycoses, infectious complications in graft-versus-host disease, and antimicrobial resistance patterns in vulnerable populations.

Dr. Ashraf has contributed to clinical research as sub-investigator for industry-sponsored trials, including pneumococcal vaccination efficacy studies and phage therapy for Staphylococcus aureus bacteremia. Her committee work encompasses Antimicrobial Stewardship and Infection Prevention initiatives at UPMC Hamot.

Current institutional affiliations include the Institute of Human Virology at the University of Maryland, where she integrates clinical care with research on immunocompromised host infections through multidisciplinary teams focused on virology and infectious disease management.